Cite
Use of acute phase proteins for the clinical assessment and management of canine leishmaniosis: general recommendations
MLA
L. J. Bernal, et al. “Use of Acute Phase Proteins for the Clinical Assessment and Management of Canine Leishmaniosis: General Recommendations.” BMC Veterinary Research, vol. 14, June 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a0425f0f6b23834db7a745dbef65e19e&authtype=sso&custid=ns315887.
APA
L. J. Bernal, Laia Solano-Gallego, Gad Baneth, Silvia Martínez-Subiela, Tommaso Furlanello, Fernando Tecles, Luis Pardo-Marín, José J. Cerón, & Marco Caldin. (2018). Use of acute phase proteins for the clinical assessment and management of canine leishmaniosis: general recommendations. BMC Veterinary Research, 14.
Chicago
L. J. Bernal, Laia Solano-Gallego, Gad Baneth, Silvia Martínez-Subiela, Tommaso Furlanello, Fernando Tecles, Luis Pardo-Marín, José J. Cerón, and Marco Caldin. 2018. “Use of Acute Phase Proteins for the Clinical Assessment and Management of Canine Leishmaniosis: General Recommendations.” BMC Veterinary Research 14 (June). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a0425f0f6b23834db7a745dbef65e19e&authtype=sso&custid=ns315887.